Daniel Albert

Frederick Allison Davis Professor of Ophthalmology and Visual Sciences and Director of the Eye Pathology Laboratory at the University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin

Co-founder of the McPherson Eye Research Institute, Daniel Albert’s research focuses on ocular tumors, specifically melanoma and retinoblastoma, using transgenic mice to investigate the molecular biology of these tumors. His investigations into the anti-tumor properties of vitamin D compounds, and the finding that they can cause apoptosis and block tumor angiogenesis to inhibit growth of retinoblastoma cells in vitro, has left Albert hopeful that an effective therapeutic intervention will emerge. More recently, he has studied resveratrol, which he has found to inhibit and sometimes block tumor growth in animal models of cancer; based on his work, formulations of resveratrol and effective ways to deliver the drug could serve as an efficacious treatment for uveal melanoma and for the prevention or treatment of metastatic disease. Beyond his laboratory and clinical work, Albert is a renowned ophthalmic historian, having published widely in the field, including texts that encompass the breadth of ophthalmic history.

Part of the Power List 2016

Welcome to The Power List 2016 – our second foray into the Top 100 most influential people in the world of ophthalmology.

Though we realize our list can (and should) never be definitive, who can argue that the faces within – both familiar and new – do not beautifully highlight the brilliance and diversity found within the field?

Here, we celebrate 100 reasons to be proud of ophthalmology.

Go to The Power List 2016